|
|
News for Healthier Living
Mayo Clinic-Led Study Finds No Improvement in Overall Survival From Longer Multiple Myeloma Maintenance Therapy
A major national cooperative group clinical trial led by Mayo Clinic researchers found that continuing maintenance therapy with lenalidomide beyond two years after initial treatment for standard-risk multiple myeloma did not improve overall survival compared with stopping treatment after two years.
July 15, 2026
July 24 2026July 23 2026July 22 2026July 21 2026July 20 2026July 17 2026July 16 2026July 15 2026July 14 2026July 13 2026July 12 2026
|
|
|
|
|